CSIR Technology Portal
CSIR Technology Portal

 Technology Profile

Title:

Promising Novel Therapeutics for Strokes and Cardiac Maladies
Value Proposition:

Process for the preparation of clot specific PEGylated-streptokinase with increased half-life.
Summary Application:

PEGylated-streptokinase find wide application in novel therapeutics for Strokes and Cardiac Maladies.
Advantages:
  • This is a cutting-edge technology that has a truly international potential since it can compete with the most advanced clot-buster drug currently available (TPA, tissue plasminogen activator).
  • The technology will be sufficiently scaled-up in-house so that after transfer to a commercial partner it has a minimum take-off period.
Commercialization Status: Licensed awaiting commercialisation
Tech. Readiness Level:
CSIR-Institute of Microbial Technology
CSIR-Institute of Microbial Technology[CSIR-IMTECH]
:  director[at]imtech[dot]res[dot]in
:91-172-2690550
:https://www.imtech.res.in
Industrial Applications: Biological Science Processes/Methods [Biological Science] Biomolecules [Biological Science] Biotechnology [Biological Science]
Patent(s): IN280371